MACULAR HOLE CLOSURE WITH TRIAMCINOLONE-ASSISTED INTERNAL LIMITING MEMBRANE PEELING

Internal limiting membrane Acetonide
DOI: 10.1097/iae.0b013e31817d8be1 Publication Date: 2008-10-06T07:12:50Z
ABSTRACT
In Brief Purpose: To evaluate the anatomic and visual outcomes of patients treated with triamcinolone-assisted internal membrane peeling for macular hole. Methods: A retrospective chart review 37 consecutive cases done by a single vitreoretinal surgeon idiopathic All surgery involved limiting peeling. had at least 3-month follow-up. Main outcome measures included hole closure, acuity, operative complications. Results: Mean follow-up was 11 months (range, 3–56 months). Anatomic closure achieved in 36 eyes (97%). overall preoperative acuity 20/150 final 20/63 (P < 0.0001). Nineteen (51%) best corrected most recent postoperative visit ≥20/50. There were no Conclusions: Triamcinolone-assisted peel is an effective surgical technique surgery. Use triamcinolone acetonide did not adversely impact closure. rates compared favorably published literature on Visual pars plana vitrectomy holes. Hole (97%) mean best-corrected 20/63. Triamcinolone can be used as adjunct to assist without compromising or outcomes.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (38)
CITATIONS (21)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....